These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 382537)

  • 1. Transfusion of blood components and skin allograft survival in rabbits.
    Fagiolo U; Corsano A; Zanon GF; Zannini G; Sogaro F; Lise M
    Transplant Proc; 1979 Jun; 11(2):1446-7. PubMed ID: 382537
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of peripheral blood components on allograft survival.
    Wakely E; Shelby J; Corry RJ
    Transplantation; 1985 Jul; 40(1):113-4. PubMed ID: 3892790
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of blood transfusion on skin allograft survival in immunosuppressed mice.
    Okazaki H; Maki T; Wood ML; Monaco AP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):515-7. PubMed ID: 7022884
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged allograft survival following cell transfusions.
    Baldwin WM; Null WL; Tilney NL
    Surg Forum; 1977; 28():334-5. PubMed ID: 364727
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological support of component blood transfusion therapy].
    Shablin VN; Serova LD; Abdulkadyrov KM; Mel'nikova VN
    Probl Gematol Pereliv Krovi; 1978 Aug; 23(8):3-7. PubMed ID: 683985
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine dosage requirements for rabbit skin allograft enhancement due to perioperative blood transfusion and cyclosporine synergy.
    Masendycz PJ; Dumble LJ; Francis DM; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2895-7. PubMed ID: 3551232
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of rabbit skin allograft survival by pretransplant and peroperative hepatic antigen treatments.
    Mitchell SV; Dumble LJ; Plenter RJ; Millar RJ; Clunie GJ
    Transplant Proc; 1990 Oct; 22(5):2097-8. PubMed ID: 2219306
    [No Abstract]   [Full Text] [Related]  

  • 8. [Formation of anti-leukocyte antibody and anti-platelet antibody and its effects on blood component transfusion].
    Shimoyama M; Minato K; Ideura Y; Kimura K
    Nihon Rinsho; 1977 Dec; 35(12):4146-54. PubMed ID: 342757
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cross immunization between brothers against the leukocyte and platelet antigens of the Hu-1 system].
    Dausset J; L Calvez H; Sasportes M; Rapaport FT
    Nouv Rev Fr Hematol; 1967; 7(5):643-62. PubMed ID: 4230107
    [No Abstract]   [Full Text] [Related]  

  • 10. HL-A in connection with blood transfusion.
    Engelfriet CP; van Loghem JJ
    Haematologia (Budap); 1974; 8(1-4):267-72. PubMed ID: 4618231
    [No Abstract]   [Full Text] [Related]  

  • 11. Alloimmunization by leukocyte-rich or leukocyte-poor random single donor platelets.
    Gmür J; Burger J; Sauter C; Oelz O; Frick PG
    Prog Clin Biol Res; 1990; 337():45-8. PubMed ID: 2191337
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical importance of leukocyte isoantigens].
    Mayr WR
    Wien Klin Wochenschr; 1973 May; 85(21):373-8. PubMed ID: 4599822
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical importance of leukocyte isoantigens].
    Mayr WR
    Wien Klin Wochenschr; 1973 May; 85(21):373-8. PubMed ID: 4593789
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical importance of leukocyte isoantigens].
    Mayr WR
    Wien Med Wochenschr; 1973 May; 25(21):373-8. PubMed ID: 4576445
    [No Abstract]   [Full Text] [Related]  

  • 15. [Targetted hemotherapy with special reference to the cellular components].
    Dörner R
    Dtsch Med Wochenschr; 1990 Jul; 115(27):1066-72. PubMed ID: 2194776
    [No Abstract]   [Full Text] [Related]  

  • 16. Allogeneic platelets increase the survival of rat renal allografts.
    Hibberd AD; Scott LJ
    Transplantation; 1983 Jun; 35(6):622-4. PubMed ID: 6346601
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of canine cardiac allograft survival using donor-specific buffy coat pretransfusions.
    Kurlansky PA; Dresdale AR; Pierson R; McManus RP; Michler RE; Sachs H; Thomas WG; Lau H; Hardy MA; Marboe C
    Transplantation; 1986 Jul; 42(1):98-101. PubMed ID: 3523892
    [No Abstract]   [Full Text] [Related]  

  • 18. Conditions required for donor passenger leukocytes in the induction of tolerance by rat liver grafts.
    Sriwatanawongsa V; Davies HS; Brons IG; White DJ; Jamieson NV; Calne RY
    Transplant Proc; 1993 Oct; 25(5):2855. PubMed ID: 8212260
    [No Abstract]   [Full Text] [Related]  

  • 19. Mouse skin allograft model for study of pregraft blood transfusion.
    Maki T; Okazaki H; Wood ML; Monaco AP
    Transplant Proc; 1982 Jun; 14(2):394-6. PubMed ID: 7051485
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfusion-induced skin allograft enhancement across an H-2 class-I mismatch is caused by a clonal deletion of donor-specific cytotoxic T-lymphocyte precursors within the allograft.
    van Twuyver E; Kast WM; Mooijaart RJ; Melief CJ; de Waal LP
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1169-70. PubMed ID: 2650087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.